Gendicine
First approved gene therapy for cancer (China NMPA). Recombinant adenovirus delivering wild-type p53 gene for head and neck squamous cell carcinoma.
No Hospitals found for this treatment modalitie.
First approved gene therapy for cancer (China NMPA). Recombinant adenovirus delivering wild-type p53 gene for head and neck squamous cell carcinoma.
No Hospitals found for this treatment modalitie.